Cargando…

Modeling precision treatment of breast cancer

BACKGROUND: First-generation molecular profiles for human breast cancers have enabled the identification of features that can predict therapeutic response; however, little is known about how the various data types can best be combined to yield optimal predictors. Collections of breast cancer cell li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daemen, Anneleen, Griffith, Obi L, Heiser, Laura M, Wang, Nicholas J, Enache, Oana M, Sanborn, Zachary, Pepin, Francois, Durinck, Steffen, Korkola, James E, Griffith, Malachi, Hur, Joe S, Huh, Nam, Chung, Jongsuk, Cope, Leslie, Fackler, Mary Jo, Umbricht, Christopher, Sukumar, Saraswati, Seth, Pankaj, Sukhatme, Vikas P, Jakkula, Lakshmi R, Lu, Yiling, Mills, Gordon B, Cho, Raymond J, Collisson, Eric A, van’t Veer, Laura J, Spellman, Paul T, Gray, Joe W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937590/ https://www.ncbi.nlm.nih.gov/pubmed/24176112 http://dx.doi.org/10.1186/gb-2013-14-10-r110

Ejemplares similares

Erratum to: Modeling precision treatment of breast cancer
por: Daemen, Anneleen, et al.
Publicado: (2015)

A robust prognostic signature for hormone-positive node-negative breast cancer
por: Griffith, Obi L, et al.
Publicado: (2013)

Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib
por: Daemen, Anneleen, et al.
Publicado: (2012)

Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer
por: Korkola, James E., et al.
Publicado: (2015)

Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer
por: Korkola, James E., et al.
Publicado: (2017)

Do Breast Cancer Cell Lines Provide a Relevant Model of the Patient Tumor Methylome?
por: Cope, Leslie M., et al.
Publicado: (2014)

Clinical implications of neoepitope landscapes for adult and pediatric cancers
por: Feng, Yang-Yang, et al.
Publicado: (2017)

'Omic approaches to preventing or managing metastatic breast cancer
por: Griffith, Obi L, et al.
Publicado: (2011)

OMIC-13. THE ROLE OF COPY NUMBER ALTERATIONS IN PREDICTING SURVIVAL AND INFLUENCING TREATMENT OF CHILDHOOD BRAIN TUMORS
por: Freshour, Sharon, et al.
Publicado: (2021)

Informatics for RNA Sequencing: A Web Resource for Analysis on the Cloud
por: Griffith, Malachi, et al.
Publicado: (2015)

ATM Suppresses SATB1-Induced Malignant Progression in Breast Epithelial Cells
por: Ordinario, Ellen, et al.
Publicado: (2012)

Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling
por: Hill, Steven M., et al.
Publicado: (2017)

Best practices for bioinformatic characterization of neoantigens for clinical utility
por: Richters, Megan M., et al.
Publicado: (2019)

DNA methylation markers predict recurrence-free interval in triple-negative breast cancer
por: Fackler, Mary Jo, et al.
Publicado: (2020)

GenVisR: Genomic Visualizations in R
por: Skidmore, Zachary L., et al.
Publicado: (2016)

Unraveling the chaotic genomic landscape of primary and metastatic canine appendicular osteosarcoma with current sequencing technologies and bioinformatic approaches
por: Chu, Shirley, et al.
Publicado: (2021)

Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors
por: Downs, Bradley M., et al.
Publicado: (2021)

Quantification of sensitivity and resistance of breast cancer cell lines to anti-cancer drugs using GR metrics
por: Hafner, Marc, et al.
Publicado: (2017)

pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens
por: Hundal, Jasreet, et al.
Publicado: (2016)

Normalization of drug and therapeutic concepts with Thera-Py
por: Cannon, Matthew, et al.
Publicado: (2023)

ORegAnno 3.0: a community-driven resource for curated regulatory annotation
por: Lesurf, Robert, et al.
Publicado: (2016)

Splicing factor SF3B1 promotes endometrial cancer progression via regulating KSR2 RNA maturation
por: Popli, Pooja, et al.
Publicado: (2020)

GenomeGraphs: integrated genomic data visualization with R
por: Durinck, Steffen, et al.
Publicado: (2009)

Standardizing And Democratizing Access To Cancer Molecular Diagnostic Test Data From Patients To Drive Translational Research
por: Madhavan, Subha, et al.
Publicado: (2018)

Cancer Immunogenomics: Computational Neoantigen Identification and Vaccine Design
por: Hundal, Jasreet, et al.
Publicado: (2017)

DGIdb 3.0: a redesign and expansion of the drug–gene interaction database
por: Cotto, Kelsy C, et al.
Publicado: (2018)

Text-mining clinically relevant cancer biomarkers for curation into the CIViC database
por: Lever, Jake, et al.
Publicado: (2019)

Integration of the Drug–Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts
por: Freshour, Sharon L, et al.
Publicado: (2020)

HER2 is not a cancer subtype but rather a pan-cancer event and is highly enriched in AR-driven breast tumors
por: Daemen, Anneleen, et al.
Publicado: (2018)

Accounting for proximal variants improves neoantigen prediction
por: Hundal, Jasreet, et al.
Publicado: (2018)

Sex- and Mutation-Specific p53 Gain-of-Function Activity in Gliomagenesis
por: Rockwell, Nathan C., et al.
Publicado: (2021)

Targeting mitochondria in cancer therapy could provide a basis for the selective anti-cancer activity
por: Rozanov, Dmitri, et al.
Publicado: (2019)

A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs
por: Tatarova, Zuzana, et al.
Publicado: (2022)

Subtypes of Pancreatic Ductal Adenocarcinoma and Their Differing Responses to Therapy
por: Collisson, Eric A., et al.
Publicado: (2011)

Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer
por: Freshour, Sharon L., et al.
Publicado: (2023)

Endothelial cells are a key target of IFN-g during response to combined PD-1/CTLA-4 ICB treatment in a mouse model of bladder cancer
por: Freshour, Sharon L., et al.
Publicado: (2023)

Analysis of molecular inversion probe performance for allele copy number determination
por: Wang, Yuker, et al.
Publicado: (2007)

Timing chromosomal abnormalities using mutation data
por: Durinck, Steffen, et al.
Publicado: (2011)

Development of an Automated Liquid Biopsy Assay for Methylated Markers in Advanced Breast Cancer
por: Fackler, Mary Jo, et al.
Publicado: (2022)

Expanding the Diversity of Imaging-Based RNAi Screen Applications Using Cell Spot Microarrays
por: Rantala, Juha K., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_f5st74jeosco9r2d63e7gmhqbd